Go Deep
Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,368 | 61.1 | 7.34 | 0.03 | 225.00 |
Arvee Laboratories (India) Ltd. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 172,253,000.0 | 108,041,000.0 | 97,795,000.0 | 34,505,000.0 |
| Net Profit | 16,941,000.0 | 5,202,000.0 | 18,269,000.0 | 101,000.0 |
| EPS | 1.5 | 0.5 | 1.7 | 0.0 |
Arvee Laboratories (India) Ltd. Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 314,391,570.0 | 384,383,820.0 | 303,422,040.0 | 612,764,590.0 | — |
| Net Profit | 25,263,380.0 | 21,473,100.0 | 10,518,350.0 | 41,190,020.0 | — |
| EPS | 2.3 | 1.9 | 0.9 | 3.7 | — |
Arvee Laboratories (India) Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 428,862,710.0 | 375,742,860.0 | 385,632,170.0 | 386,852,930.0 | — |
| Total Liabilities | 90,986,020.0 | 63,129,550.0 | 94,491,950.0 | 106,231,070.0 | — |
| Total Equity | 337,876,690.0 | 312,613,310.0 | 291,140,220.0 | 280,621,860.0 | — |
Owes vs Owns
Arvee Laboratories (India) Ltd. owed ₹0.21 for every ₹1 it owned in Mar 2026, down from ₹0.27 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.21× | 0.17× | 0.25× | 0.27× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Arvee Laboratories (India) Ltd. Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 7.6%Receivables 24.4%Inventory 21.4%Fixed assets (tangible) 41.1%Other assets 5.5%
How it's funded — Mar 2026
Long-term debt 2.6%Payables 14.9%Other liabilities 3.7%Shareholders' equity 78.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3.3 | 4.9 | 1.9 | 0.9 |
| Receivables | 10.5 | 8.4 | 6.1 | 12.3 |
| Inventory | 9.2 | 4.6 | 6.4 | 4.6 |
| Fixed assets (tangible) | 17.6 | 16.0 | 15.3 | 14.2 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 1.1 | 5.7 | 2.3 |
| Other assets | 2.3 | 2.6 | 3.2 | 4.4 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 1.1 | 1.0 | 1.0 | 1.0 |
| Payables | 6.4 | 3.3 | 6.6 | 7.9 |
| Other liabilities | 1.6 | 2.0 | 1.8 | 1.7 |
| Shareholders' equity | 33.8 | 31.3 | 29.1 | 28.1 |
| Net tangible assets | 33.8 | 31.3 | 29.1 | 28.1 |
Arvee Laboratories (India) Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -1,197,680.0 | -2,061,700.0 | 36,635,380.0 | 29,289,390.0 | — |
| Investing Activities | 5,035,050.0 | -13,151,240.0 | -21,632,820.0 | -12,575,890.0 | — |
| Financing Activities | -1,554,210.0 | -1,177,290.0 | -1,876,530.0 | -24,169,920.0 | — |